How shorted is REVIVA PHARMACEUTICALS HOLDINGS, INC. right now?

14.57% of REVIVA PHARMACEUTICALS HOLDINGS, INC.'s (RVPH) shares outstanding were reported short for settlement date 30 Apr 2026, per FINRA's consolidated short interest report.

What does this number include?

FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.

Why does it only update twice a month?

US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.

Which funds are short?

US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.

How shorted is REVIVA PHARMACEUTICALS HOLDINGS, INC.?

14.57%

of shares outstanding reported short · settlement date 30 Apr 2026

vs previous report: +3.41
5 reports (~10 weeks): −6.01

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

<iframe src="https://howshorted.com/embed/us/rvph/" width="100%" height="430" style="border:0" loading="lazy" title="REVIVA PHARMACEUTICALS HOLDINGS, INC. short interest chart"></iframe>
<p>Source: FINRA data compiled by <a href="https://howshorted.com/us/company/rvph/">howshorted.com</a></p>

Cite this page

Short position data for REVIVA PHARMACEUTICALS HOLDINGS, INC.: FINRA, compiled by howshorted.com, settlement date 30 Apr 2026. https://howshorted.com/us/company/rvph/

History

Settlement date	Short %	Change
30 Apr 2026	14.57%	+3.41
15 Apr 2026	11.16%	−3.16
31 Mar 2026	14.32%	−2.95
27 Feb 2026	17.27%	−1.92
13 Feb 2026	19.19%	−1.39
30 Jan 2026	20.58%	+0.09
15 Jan 2026	20.49%	+1.84
31 Dec 2025	18.65%	−3.64
15 Dec 2025	22.29%	+2.17
28 Nov 2025	20.12%	+0.07
14 Nov 2025	20.05%	−12.87
31 Oct 2025	32.92%	+0.17
15 Oct 2025	32.75%	+12.37
30 Sep 2025	20.38%	+1.25
15 Sep 2025	19.13%	−0.15
29 Aug 2025	19.28%	+2.21
15 Aug 2025	17.07%	−8.50
31 Jul 2025	25.57%	–

Frequently asked questions

How shorted is REVIVA PHARMACEUTICALS HOLDINGS, INC. right now?: 14.57% of REVIVA PHARMACEUTICALS HOLDINGS, INC.'s (RVPH) shares outstanding were reported short for settlement date 30 Apr 2026, per FINRA's consolidated short interest report.
What does this number include?: FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?: US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?: US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.